3 years 4.07
Extreme 4.0705
12.51
5 years 4.07
Extreme 4.0705
34.51
10 years 1.97
Extreme 1.974
34.51
Manager TitleAgeSince
Chief Executive Officer - 2025-09-14
Director of Finance/CFO - 2026-05-31
Chief Tech/Sci/R&D Officer - 2025-10-31
Date Insider Type Main position Quantity % Market Cap. Importance
2/5/25 Issuer sale

Chief Operating Officer

339,314 0.5305%
2/5/25 Issuer sale

Chief Executive Officer

1,064,583 1.6644%
2/5/25 Issuer sale

Director

168,820 0.2639%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%-.--% - - 799M
+0.22%-0.14%+55.12%+128.82% 1,140B
+0.91%+3.61%+41.21%+84.57% 641B
-0.12%-0.93%+25.59%+106.14% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.86%-4.37%+61.16%+37.93% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.75%+2.05%+53.85%+71.25% 240B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.44%+1.16%+38.36%+76.06% 445.98B
Weighted average by Cap. +0.44%+0.96%+42.20%+88.48%
Logo Avid Bioservices, Inc.
EAvid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.
Employees
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. CDMO Stock